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 Abstract 
Objective:  This study examines the physiologic impact of a glucose load on serum testosterone 
(T) levels in men with varying glucose tolerance (GT).  
 
Design: Cross-sectional study 
 
Patients and Methods: 74 men (19-74 years, mean 51.4 ± 1.4 years) underwent a standard 75-g 
oral glucose tolerance test with blood draws at 0, 30, 60, 90, and 120 min.  Fasting serum 
glucose, insulin, total T (and calculated free T), LH, SHBG, leptin and cortisol were measured. 
 
Results: 57% of the men had normal GT, 30% had impaired GT, and 13% had newly diagnosed 
type 2 diabetes. Glucose ingestion was associated with a 25% decrease in mean T levels (delta = 
–4.2 ± 0.3 nmol/L, p <0.0001).  T levels remained suppressed at 120 minutes compared to 
baseline (13.7 ± 0.6 vs. 16.5 ± 0.7 nmol/L, p <0.0001) and did not differ across GT or BMI. Of 
the 66 men with normal T levels at baseline, 10 (15%) had levels which decreased to the 
hypogonadal range (<9.7 nmol/L) at one or more time points.  SHBG, LH, and cortisol levels 
were unchanged. Leptin levels decreased from baseline at all time points (p <0.0001). 
 
Conclusions: Glucose ingestion induces a significant reduction in total and free T levels in men, 
which is similar across the spectrum of glucose tolerance. This decrease in T appears to be due to 
a direct testicular defect but the absence of compensatory changes in LH suggests an additional 
central component.  Men found to have low non-fasting T levels should be reevaluated in the 
fasting state.  
 INTRODUCTION 
More than two thirds of American adults are overweight or obese.  This trend creates significant 
public health concerns related to the growing numbers of individuals with insulin resistance, 
metabolic syndrome, and type 2 diabetes 1.   We, and others, have demonstrated an inverse 
relationship between testosterone (T) levels and insulin resistance in men with type 2 diabetes 
and the metabolic syndrome 2-5.  The combination of an aging American public and an obesity 
epidemic has produced a growing awareness of hypogonadism reflected in a significant increase 
in the annual number of  T prescriptions 6.  The decision to prescribe T is often based on a single 
blood sample, despite well documented diurnal and day-to-day variability in men 7, 8 and clinical 
recommendations by expert panels that two or more morning samples be drawn for assessment 
of T levels 9. However, no emphasis has been placed on when a sample for T measurement 
should be drawn in relation to food intake or if it should be obtained in the fasting state.   
 
To date, three studies have investigated the T response in men to different caloric and 
macronutrient (fat) content in meals.  Depending on the meal composition, these studies 
demonstrated either a postprandial decrease in T ranging from 15 to 40%, or no change in T 
levels 10-12.  Yet, the differences in meal size and macronutrient proportions create ambiguity 
regarding what caused, or failed to cause, a decrease in T levels.  In addition, three previous 
studies have reported that in men given an oral glucose load, serum T levels decreased by 
approximately 10% 13, 14% 14 and 30% 15, respectively. However, conclusions from these studies 
are limited by both small sample size and the fact that all subjects had normal glucose tolerance.   
 
 Nutrient ingestion initiates a complex cascade of physiological processes, including the secretion 
of a variety of peripheral signals that act at the hypothalamus.  Interestingly, many of the signals 
implicated in energy homeostasis have also been demonstrated to affect the reproductive axis 16.  
In contrast to the inverse relationship between T and insulin resistance in men, in vitro studies 
demonstrate the stimulatory effect of insulin on the reproductive axis. Insulin has been shown to 
promote gonadotropin-releasing hormone secretion in a hypothalamic neuronal cell line 17, 
stimulate gonadotropin secretion from pituitary cell cultures 18, and stimulate T secretion from 
cultured Leydig cells 19.  Further, pharmacologic doses of insulin have been shown to 
significantly increase serum T levels in healthy men during hyperinsulinemic-euglycemic clamp 
studies 4.  To date, the mechanism underlying these changes in T has not been defined.   
 
Thus, the aims of this study were to: i) examine the physiologic impact of an oral glucose load 
on serum T levels in a cohort of men diverse in terms of age and BMI; ii) determine if the T 
response varies with glucose tolerance; iii) establish if changes in T levels have a neuroendocrine 
basis or result from a direct testicular effect; and iv) explore mechanisms that might account for 
any change.  
 
PATIENTS AND METHODS 
A total of 74 healthy, adult males (range: 19-74 years, mean: 51.4 ± 1.4) were included in the 
study.  This community dwelling group included fifty-nine (80%) Caucasian, 12 (16%) African 
American, 1 (1%) Asian, and 2 (3%) Hispanic/Latino men.  Subjects were excluded if they had a 
history of chronic illness, reproductive disorders, prostate cancer, type 2 diabetes, or use of 
medications known to interfere with androgen synthesis/action or glucose homeostasis.  All 
 subjects had undergone a normal puberty and had normal serum prolactin and thyroid 
stimulating hormone levels.  The study was approved by the Human Research Committee of the 
Massachusetts General Hospital and all subjects provided written informed consent prior to the 
initiation of study procedures. 
 
Study subjects underwent a full physical examination including calculation of body mass index 
(BMI) from the measurement of weight in kilograms divided by the square of height in meters 
and were classified as normal weight (< 25 kg/m2), overweight (25.0-29.9 kg/ m2), or obese (≥ 
30.0 kg/ m2).   A standardized 2-hour oral glucose tolerance test (OGTT) using 75g of glucose 
was administered following a 12-hour overnight fast.  All subjects began testing between the 
hours of 08:00-09:00 AM with blood samples drawn at baseline (time 0) and at +30, +60, 
+90, and +120 minutes following glucose ingestion.  Subjects were classified as having normal 
glucose tolerance (NGT), impaired glucose tolerance (IGT), or type 2 diabetes according to 
American Diabetes Association criteria 20.  Blood samples were analyzed to measure glucose, 
insulin, T, sex hormone binding globulin (SHBG), luteinizing hormone (LH), and leptin.  Free T 
concentrations were calculated from total T and SHBG using the Vermeulen equation 21. Based 
on their total serum T level at baseline (time 0) and the normal range for our T assay, subjects 
were classified as having normal (≥9.7 nmol/L) or low (<9.7 nmol/L) T levels. Serum cortisol 
levels were assessed in a subset of subjects (n=40) at 0, 30, and 60 minutes. 
 
Assays 
All assay methods used in this study have been previously described 2, 22.  Serum T levels were 
measured using the DPC Coat-A-Count RIA kit (Diagnostics Products Corporation, Los 
 Angeles, CA) with intra- and interassay coefficients of variation (CV) of less than 10%.  Serum 
LH concentrations were determined by microparticle enzyme immunoassay using the automated 
Abbott AxSYM system (Abbott Laboratories, Chicago, IL), which had an intraassay CV of less 
than 7% and an interassay CV of less than 7.4%.  SHBG was measured using a fully automated 
system (Immulite; Siemens) with an intra and interassay CV of less than 7%.  Glucose was 
measured by the hexokinase glucose-6-phosphate dehydrogenase method (Olympus Diagnostica, 
Melville, NY).  Leptin was measured using a commercially available RIA kit (Linco Inc., St. 
Charles, MO), which had an intra- and interassay CV of less than 6%.  Immunoreactive insulin 
was determined by using a commercially available RIA kit (Linco Inc., St. Charles, MO) using 
125I-labeled human insulin and human insulin antiserum.  Serum cortisol levels were measured 
using a fully automated chemiluminescent immunoassay system [Immulite 2000, Diagnostics 
Products Corp. Inc. Los Angeles CA].  The inter-assay CV range was 11.8, 7.3, and 5.8 % for 
control sera containing from 125, 335, and 965 nmol/L respectively.  
 
Statistical Analysis 
Data are presented as mean ± SEM unless otherwise stated.   Baseline characteristics were 
compared across glucose tolerance groups using one-way ANOVA.  Repeated measures 
ANOVA was used to assess the overall time effect and test for an association between T and 
covariates at the previous time point.  A Dunnet’s test was employed to compare each time point 
to baseline levels while correctly accounting for multiple comparisons.  A random slopes model 
was used for each covariate in a separate regression model to test for an association between T 
and other covariates.  Linear association between any two variables was assessed using the 
Pearson Product Moment Correlation.  A p value < 0.05 was considered statistically significant.    
  
RESULTS 
Baseline clinical and biochemical characteristics of the study population are presented in Table 
1.  Subjects’ BMI ranged from 20.4-49.4 kg/m2 including 8 normal weight, 29 overweight, and 
37 obese subjects.  In terms of glucose tolerance, 42 subjects (57%) had NGT, 22 (30%) had 
IGT, and 10 (13%) had newly diagnosed type 2 diabetes.  At baseline (time 0), 8 men had T 
levels below the normal range (<9.7 nmol/L), while the remainder were eugonadal (n=66).  
 
In the group as a whole, serum T levels were significantly lower than baseline (p<0.0001) at all 
time points following the 75g oral glucose load (Figure 1).  Free T levels mirrored the decrease 
in total T (Fig. 1) as serum SHBG levels did not change during testing (Table 2). Interestingly, 
only one subject did not have a serum T level fall below baseline during the 2 hours of testing.  
No significant changes in LH were observed and repeated measures analysis revealed that LH 
neither exerted an effect on T levels at the same time point, nor 30 minutes earlier.  Leptin levels 
were significantly decreased at 30 minutes and the lowered level persisted throughout testing (p< 
0.0001).  No changes in plasma cortisol levels were observed (Table 2).   
 
Notably, 10 of the 66 subjects (15%) with normal T levels at baseline had a T level that fell 
below the normal range during at least one time point during the testing.  Of those 10 men, 
5 had low T levels at +30 minutes, 7 at +60 minutes, 6 at +90 minutes, and 8 at +120 minutes.  
Across the entire cohort, the time to reach nadir T level varied; 8 men (10.1%) exhibiting their 
lowest serum T at 30 minutes, 21 (28.4%) at 60 minutes, 22 (29.7%) at 90 minutes, and 23 
 (31.1%) at 120 minutes.  The mean maximum intra-individual decrease in serum T was 4.2 ± 0.3 
nmol/L, a reduction of 24.7% from baseline.   
 
When the cohort was stratified according to glucose tolerance, T levels were not different across 
the three groups during testing (Fig. 2).  Significantly decreased T levels were observed in the 
NGT group at all time points compared to baseline (p<0.0001) while the type 2 diabetes group 
was decreased (p<0.005) at 60, 90, and 120 minutes, and the IGT group showed T levels 
significantly lower than baseline only at  60 and 90 minutes (p <0.01). Neither mean values at 
each time point, nor changes from baseline in LH, leptin, free T, or SHBG in response to glucose 
differed significantly across the three groups.  Changes in T were not different between BMI 
groups (normal weight, overweight, or obese).  Further, no associations were identified between 
changes in total T levels and changes in any of the covariates examined.      
 
DISCUSSION   
The Endocrine Society guidelines for the evaluation and treatment of androgen deficiency 
syndromes in adult men recommend that a diagnosis be made only in men with consistent signs 
and symptoms as well as unequivocally low, repeated morning serum T levels 9.  To date, no 
recommendations exist regarding T measurement in relation to food intake.  Herein, we report a 
significant decrease in serum T following a standard 75g glucose load in a diverse cohort of adult 
men across a spectrum of glucose tolerance.   Further, T levels decreased by as much as 47% 
from fasting baseline levels in eugonadal men following glucose ingestion and 15% of men with 
normal T levels at baseline developed low T levels at one or more time point during the OGTT.  
Recently, a large study of over 300 men (40-97 years of age) showed that compared to non-
 fasting levels, fasting men havesignificantly higher serum T levels 23.  These data raise an 
important issue with regard to the optimal conditions under which hypogonadism should be 
assessed in men.  Based on these data we propose that men who present with signs and 
symptoms of hypogonadism and who display borderline low serum T levels should have 
morning measurements taken in a fasting state to get a clearer picture of total T levels.  This is 
particularly important as serum T levels have been shown to transiently fall well below the 
normal range in approximately 15% of healthy males over the course of a day 7.  Thus, careful 
assessment of hypogonadism in men is critical to ensure that appropriate therapeutic decisions 
are made.   
 
However, while the clinical implications for these findings may be evident, the mechanism is 
less clear.  In the present study, men exhibited on average a 25% decrease in serum T level from 
fasting levels and no differences were observed according to glucose tolerance.  These data are in 
line with previous studies reporting changes in T levels ranging from 10-30% in men with 
normal glucose tolerance 13-15.  While our data are bolstered by the diverse population studied, 
we also sought to elucidate the mechanism of these hormonal dynamics.  The first, and perhaps 
most obvious, explanation for the observed changes is a technical issue, that the measurements 
were affected by subjects’ hydration status or dilution issues.  While these may have been 
contributing factors, there are several reasons why it they are unlikely to fully explain the 
observations.  First, while this is a rather crude measure of hydration status, hematocrit 
was normal in all subjects.  Second, all but 1 subject showed the same pattern of decrease.  
Third, the sheer magnitude of change makes it highly unlikely that changes could be 
explained by hydration status of dilution issues.  Another explanation for the observed 
 changes was that the stress of fasting, having an i.v. cannula inserted and being subjected to an 
OGTT stimulated cortisol levels which could, in turn, suppress T levels.  However, cortisol 
levels were unchanged in the present study, and actually decreased in prior reports 24, 25, thus 
ruling this out as a possible cause.  
 
An alternate mechanism underlying the decrease in T is that peripheral signals to the central 
nervous system such as leptin might be influencing the HPG axis.  Both insulin and leptin play 
important roles in transmitting messages to the brain on energy stores, which in turn affect 
appetite and energy expenditure 26.  Prior studies have shown that leptin levels decline 
following fasting-induced decreases in insulin 27 and are restored with refeeding 28.  
Interestingly, elevated leptin levels are associated with insulin resistance independent of 
body fat mass 29 yet insulin does not acutely stimulate leptin production 30.  Others have 
reported decreases in leptin following a meal or at 2-hours of an OGTT 31.  In contrast, the 
study reporting a 14% decrease in T with OGTT at 2 hours found no change in leptin 
levels compared to fasting baseline levels 14.  We observed a significant and sustained 
suppression of leptin following glucose ingestion similar to the observed T suppression.  
Epidemiologic studies have shown a negative correlation between T and leptin and when a 
GnRH analog is used to suppress serum T levels, both insulin and leptin levels increase 32.  
However, the changes observed in the present study were acute and therefore, it may be 
that the observed decrease in leptin is related to its diurnal secretion pattern as others have 
postulated 31. Alternatively, it may suggest a more complex relationship between 
metabolism and reproduction in men. 
 
 We hypothesized that the diminished T levels could have resulted from an inhibitory effect of 
insulin on hepatic SHBG production 33. However, SHBG levels were neither different across the 
spectrum of glucose tolerance nor did they change during the OGTT and accordingly the 
decrease in calculated free T levels mirrored that of total T.   Lastly, we considered that the 
decrease in T levels might be due to a central defect in the HPG axis.  The prior studies are 
conflicting reporting either no change in LH levels 14 or increased levels at 2-hours 13.  However, 
given the pulsatile nature of LH secretion, a single measurement of LH is often insufficient to 
characterize dynamic levels, thus limiting the inferences that can be drawn from these studies.  
Recently, a study of more than 50 men, nearly all of whom had normal glucose tolerance, 
utilized frequent blood sampling to demonstrate that glucose ingestion induced a decrease in 
pulsatile LH secretion over a 6-hour period 34.  In the current study, we evaluated LH levels at 
each of the 5 time-points during the OGTT revealing normal levels that were unchanged 
throughout.  The lack of compensatory increase in LH levels in response to a fall in serum T 
level is particularly noteworthy as one would anticipate that the decreased negative feedback of 
T would lead to increased LH levels 35.  Thus, these data appear to be consistent with a central 
defect.  
 
In summary, we demonstrate a significant decrease in serum total T and calculated free T during 
a standard 75g oral glucose tolerance test in men across a spectrum of glucose tolerance.  On 
average, T levels decreased by 25%.  Importantly, 15% of the men who were eugonadal at 
baseline developed low T levels following glucose ingestion.  The decrease in T appears to be 
due to a direct testicular defect but the absence of compensatory changes in LH suggests an 
additional central component.  Based on these data we suggest that evaluating T levels in a 
 fasting state may aid in the clinical decision making regarding testosterone supplementation for 
hypogonadism in men.   
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Table 1.  Clinical and biochemical characteristics at baseline (mean ± SEM) 
 All               subjects         
(n=74) 
Normal             
glucose tolerance      
(n=42) 
Impaired         
glucose tolerance         
(n=22) 
Type 2            
diabetes          
(n=10) 
Age (years) 51.4 ± 1.4 48.8 ± 1.2 53.8 ± 1.2 57.7 ± 2.8 
BMI (kg/m2) 30.8 ± 0.7 29.6 ± 0.6 32.6 ± 0.6 31.7 ± 1.1 
Testosterone     
(nmol/L) 16.5 ± 0.7 16.9 ± 0.9 14.9 ± 1.3 18.4 ± 1.6 
Subjects with low 
testosterone levels 
(%) 
8 (10.8%) 4 (9.5%) 3 (13.0%) 1 (11.1%) 
Glucose        
(mmol/L) 6.4 ±  0.4 4.9 ± 0.1 5.4 ± 0.1* 7.4 ± 1.1*,† 
Insulin           
(pmol/L) 78.7 ±  6.7 58.0 ± 6.7 106.3 ± 13.1* 102.9 ± 22.0* 
* P<0.05 compared to NGT,  † P<0.05 compared to IGT 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Table 2. Biochemical response to a 75g oral glucose load 
Time 0 30 60 90 120 
Glucose                      
(mmol/L) 
5.4 ±  0.2 8.6 ±  0.3* 9.4 ±  0.4* 8.8 ±  0.5* 7.6 ±  0.4* 
Insulin                           
(pmol/L) 
78.7 ± 6.7 403.6 ± 40.1* 452.2 ± 39.0* 486.9 ± 47.1* 422.4 ± 50.0* 
SHBG                           
(nmol/L)                                   
37.5 ± 2.4 38.4 ± 2.6 36.9 ± 2.5 38.6 ± 2.6 37.5 ± 2.4 
LH                                    
(IU/L)                                   
11.1 ± 0.8 11.5 ± 0.8 11.5 ± 0.8 12.1 ± 0.8 12.0 ± 0.9 
Leptin                                    
(ug/L)                                            
11.2 ± 1.7 6.6 ± 0.8* 6.7 ± 0.8* 6.9 ± 0.8* 6.6 ± 0.8* 
Cortisol†                                
(nmol/L)                     
248.3 ± 19.0 231.2 ± 15.7 225.1 ± 13.8 NA NA 
            * P< 0.0001 compared to Time 0; † Data obtained on random subset of 40 subjects; NA = not assessed 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 1. Changes in total testosterone (circles) and calculated free testosterone (squares) in 
response to a 75g oral glucose load (n=74).  Each time point represents mean ± SEM, asterisks 
(*) denote change from baseline (p<0.0001).  
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 Figure 2. Changes in serum testosterone levels in men with normal glucose tolerance ([circles], 
n= 42, p< 0.0001[‡] ), impaired glucose tolerance ([squares], n= 22, p <0.01 [*]), and type 2 
diabetes ([triangles], n= 10, p<0.005 [†]) in response to a 75g oral glucose load.  Each time point 
represents the mean ± SEM for the group.  P values indicate change from baseline, changes 
across groups were not significant. 
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